Active Ingredients

API's and Intermediaries

Active Pharmaceutical Ingredients

Molecraft Life Sciences Pvt Ltd is actively involved in the R&D and production of active pharmaceutical ingredients (APIs) using chemical, bio-synthesis, enzymatic and fermentation processes.

API's and Intermediaries

100 products
Available (4-(Pyridin-2-ylcarbamoyl)phenyl)boronic Acid structure

(4-(Pyridin-2-ylcarbamoyl)phenyl)boronic Acid

Acalabrutinib Intermediate — boronic acid coupling partner

CAS No.
850568-25-1
M. Formula
C12H11BN2O3
MW
242.04
Available Benzyl (S)-2-(8-amino-1-bromoimidazo[1,5-a]pyrazin-3-yl)pyrrolidine-1-carboxylate structure

Benzyl (S)-2-(8-amino-1-bromoimidazo[1,5-a]pyrazin-3-yl)pyrrolidine-1-carboxylate

Acalabrutinib KSM — pyrrolidine-imidazopyrazine core

CAS No.
1420478-88-1
M. Formula
C18H18BrN5O2
MW
416.28
Available N-(Benzyloxycarbonyl)-L-proline structure

N-(Benzyloxycarbonyl)-L-proline

Acalabrutinib KSM — Cbz-protected L-proline

CAS No.
1148-11-4
M. Formula
C13H15NO4
MW
249.26
Available N-[(2S)-2-[[(Methylsulfonyl)oxy]methyl]-1-oxo-3-phenylpropyl]-glycine ethyl ester structure

N-[(2S)-2-[[(Methylsulfonyl)oxy]methyl]-1-oxo-3-phenylpropyl]-glycine ethyl ester

Alvimopan Dihydrate Intermediate

CAS No.
1314751-85-3
M. Formula
C15H21NO6S
MW
343.39
Available N-Methoxycarbonyl-L-tert-leucine structure

N-Methoxycarbonyl-L-tert-leucine

Atazanavir Sulfate KSM

CAS No.
162537-11-3
M. Formula
C8H15NO4
MW
189.21
Available (S)-1-Benzylpyrrolidin-3-ol structure

(S)-1-Benzylpyrrolidin-3-ol

Barnidipine HCl Chiral KSM

CAS No.
101385-90-4
M. Formula
C11H15NO
MW
177.25
Available 2-(2-(4-(2-(4-(1-(2-Ethoxyethyl)-1H-benzo[d]imidazol-2-yl)piperidin-1-yl)ethyl)phenyl)propan-2-yl)-4,4-dimethyl-4,5-dihydrooxazole structure

2-(2-(4-(2-(4-(1-(2-Ethoxyethyl)-1H-benzo[d]imidazol-2-yl)piperidin-1-yl)ethyl)phenyl)propan-2-yl)-4,4-dimethyl-4,5-dihydrooxazole

Bilastine Penultimate Intermediate

CAS No.
202189-77-3
M. Formula
C32H44N4O2
MW
516.73
Available tert-Butyl 4-(1H-benzo[d]imidazol-2-yl)piperidine-1-carboxylate structure

tert-Butyl 4-(1H-benzo[d]imidazol-2-yl)piperidine-1-carboxylate

Bilastine Intermediate — Boc-protected benzimidazole piperidine

CAS No.
953071-73-3
M. Formula
C17H23N3O2
MW
301.39
Available 4-tert-Butyl-N-(6-chloro-5-(2-methoxyphenoxy)-2,2'-bipyrimidin-4-yl)benzenesulfonamide structure

4-tert-Butyl-N-(6-chloro-5-(2-methoxyphenoxy)-2,2'-bipyrimidin-4-yl)benzenesulfonamide

Bosentan Hydrate Penultimate Intermediate

CAS No.
150727-06-3
M. Formula
C25H24ClN5O4S
MW
526.01
Available 5-(2-Methoxyphenoxy)-[2,2'-bipyrimidine]-4,6(1H,5H)-dione structure

5-(2-Methoxyphenoxy)-[2,2'-bipyrimidine]-4,6(1H,5H)-dione

Bosentan Hydrate Intermediate

CAS No.
150728-12-4
M. Formula
C15H12N4O4
MW
312.29
Available 7-Hydroxyquinolin-2(1H)-one structure

7-Hydroxyquinolin-2(1H)-one

Brexpiprazole KSM — 7-hydroxycarbostyril

CAS No.
70500-72-0
M. Formula
C9H7NO2
MW
161.16
Available 8-(Benzo[b]thiophen-4-yl)-5,8-diazaspiro[4.5]decan-5-ium Bromide structure

8-(Benzo[b]thiophen-4-yl)-5,8-diazaspiro[4.5]decan-5-ium Bromide

Brexpiprazole Diazaspirodecane Intermediate

CAS No.
2143944-65-2
M. Formula
C16H21BrN2S
MW
353.32
Available (2R,3S,5R)-5-(5-((E)-2-Bromovinyl)-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-2-(((4-chlorobenzoyl)oxy)methyl)tetrahydrofuran-3-yl 4-chlorobenzoate structure

(2R,3S,5R)-5-(5-((E)-2-Bromovinyl)-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-2-(((4-chlorobenzoyl)oxy)methyl)tetrahydrofuran-3-yl 4-chlorobenzoate

Brivudine Protected Nucleoside Intermediate

CAS No.
87531-10-0
M. Formula
C25H19BrCl2N2O7
MW
610.24
Available (E)-3-(2,4-Dioxo-1,2,3,4-tetrahydropyrimidin-5-yl)acrylic acid structure

(E)-3-(2,4-Dioxo-1,2,3,4-tetrahydropyrimidin-5-yl)acrylic acid

Brivudine KSM — uracil acrylate

CAS No.
57412-59-6
M. Formula
C7H6N2O4
MW
182.13
Available 4-Glycidyloxycarbazole structure

4-Glycidyloxycarbazole

Carvedilol KSM — glycidyl carbazole ether

CAS No.
51997-51-4
M. Formula
C15H13NO2
MW
239.27
Available (R)-1-(Naphthalen-1-yl)ethanamine HCl structure

(R)-1-(Naphthalen-1-yl)ethanamine HCl

Cinacalcet HCl Chiral KSM

CAS No.
82572-04-1
M. Formula
C12H14ClN
MW
207.70
Available 3-(Trifluoromethyl)cinnamaldehyde structure

3-(Trifluoromethyl)cinnamaldehyde

Cinacalcet HCl Intermediate — trifluoromethylcinnamaldehyde

CAS No.
262268-58-6
M. Formula
C10H7F3O
MW
200.16
Available 5-Cyanophthalide structure

5-Cyanophthalide

Citalopram KSM — 5-cyanophthalide

CAS No.
82104-74-3
M. Formula
C9H5NO2
MW
159.14
Available 4-(Methylamino)-3-nitrobenzoic Acid structure

4-(Methylamino)-3-nitrobenzoic Acid

Dabigatran Intermediate — methylamino nitrobenzoic acid

CAS No.
41263-74-5
M. Formula
C8H8N2O4
MW
196.16
Available 4-Aminobenzonitrile structure

4-Aminobenzonitrile

Dabigatran KSM — 4-aminobenzonitrile

CAS No.
873-74-5
M. Formula
C7H6N2
MW
118.14
Available 4-Chloro-3-nitrobenzoic Acid structure

4-Chloro-3-nitrobenzoic Acid

Dabigatran KSM — 4-chloro-3-nitrobenzoic acid

CAS No.
96-99-1
M. Formula
C7H4ClNO4
MW
201.56
Available Ethyl 3-(2-(((4-cyanophenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate structure

Ethyl 3-(2-(((4-cyanophenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate

Dabigatran Etexilate Key Intermediate

CAS No.
211915-84-3
M. Formula
C27H26N6O3
MW
482.53
Available Ethyl 3-(2-Pyridylamino)propionate structure

Ethyl 3-(2-Pyridylamino)propionate

Dabigatran Intermediate — pyridylamino propionate ester

CAS No.
103041-38-9
M. Formula
C10H14N2O2
MW
194.23
Available Ethyl 3-[[4-(Methylamino)-3-nitrobenzoyl]-pyridin-2-ylamino]propanoate structure

Ethyl 3-[[4-(Methylamino)-3-nitrobenzoyl]-pyridin-2-ylamino]propanoate

Dabigatran Advanced Intermediate

CAS No.
429659-01-8
M. Formula
C18H20N4O5
MW
372.38
Available N-(4-Cyanophenyl)glycine structure

N-(4-Cyanophenyl)glycine

Dabigatran Intermediate — cyanophenylglycine

CAS No.
42288-26-6
M. Formula
C9H8N2O2
MW
176.17
Available N-[3-Amino-4-(methylamino)benzoyl]-N-2-pyridinyl-β-alanine Ethyl Ester structure

N-[3-Amino-4-(methylamino)benzoyl]-N-2-pyridinyl-β-alanine Ethyl Ester

Dabigatran Penultimate Intermediate

CAS No.
212322-56-0
M. Formula
C18H22N4O3
MW
342.39
Available Methoxy Dapagliflozin structure

Methoxy Dapagliflozin

(2S,3R,4S,5S,6R)-2-(4-Chloro-3-(4-ethoxybenzyl)phenyl)-6-(hydroxymethyl)-2-methoxytetrahydro-2H-pyran-3,4,5-triol

CAS No.
714269-57-5
M. Formula
C22H27ClO7
MW
438.90
Available 1-(2,3-Dihydro-5-benzofuranyl)ethanone structure

1-(2,3-Dihydro-5-benzofuranyl)ethanone

Darifenacin HBr Intermediate

CAS No.
90843-31-5
M. Formula
C10H10O2
MW
162.19
Available 5-(2-Bromoethyl)-2,3-dihydrobenzofuran structure

5-(2-Bromoethyl)-2,3-dihydrobenzofuran

Darifenacin HBr Intermediate

CAS No.
127264-14-6
M. Formula
C10H11BrO
MW
227.10
Available (1-Methyl-4-piperidinyl)[3-[2-(3-chlorophenyl)ethyl]pyridinyl]methanone hydrochloride structure

(1-Methyl-4-piperidinyl)[3-[2-(3-chlorophenyl)ethyl]pyridinyl]methanone hydrochloride

Desloratadine Penultimate Intermediate

CAS No.
119770-60-4
M. Formula
C20H24Cl2N2O
MW
379.33
Available 2-Cyano-3-(3-chlorophenylethyl)pyridine structure

2-Cyano-3-(3-chlorophenylethyl)pyridine

Desloratadine Intermediate

CAS No.
31255-57-9
M. Formula
C14H11ClN2
MW
242.71
Available 4-Amino-N-[2-(4-aminophenoxy)ethyl]-N-methylbenzeneethanamine structure

4-Amino-N-[2-(4-aminophenoxy)ethyl]-N-methylbenzeneethanamine

Dofetilide Diamino Intermediate

CAS No.
115256-13-8
M. Formula
C17H23N3O
MW
285.38
Available Methyl-(4-nitrophenylethyl)-(4-nitrophenoxyethyl)amine structure

Methyl-(4-nitrophenylethyl)-(4-nitrophenoxyethyl)amine

Dofetilide Dinitro Intermediate

CAS No.
115287-37-1
M. Formula
C17H19N3O5
MW
345.36
Available 1-(3-Chloropropyl)-1,3-dihydrobenzimidazol-2-one structure

1-(3-Chloropropyl)-1,3-dihydrobenzimidazol-2-one

Domperidone Intermediate

CAS No.
62780-89-6
M. Formula
C10H11ClN2O
MW
210.66
Available 5-Chloro-1-(4-piperidinyl)-2-benzimidazolidinone structure

5-Chloro-1-(4-piperidinyl)-2-benzimidazolidinone

Domperidone Intermediate

CAS No.
53786-28-0
M. Formula
C12H14ClN3O
MW
251.71
Available (R)-1-(3-((1-methylpyrrolidin-2-yl)methyl)-5-(2-(phenylsulfonyl)vinyl)-1H-indol-1-yl)ethanone structure

(R)-1-(3-((1-methylpyrrolidin-2-yl)methyl)-5-(2-(phenylsulfonyl)vinyl)-1H-indol-1-yl)ethanone

Eletriptan HBr Intermediate

CAS No.
180637-88-1
M. Formula
C24H26N2O3S
MW
422.40
Available 2-(Benzyloxy)-1-bromo-3-nitrobenzene structure

2-(Benzyloxy)-1-bromo-3-nitrobenzene

Eltrombopag Olamine KSM

CAS No.
688363-79-3
M. Formula
C13H10BrNO3
MW
308.13
Available 2'-(Benzyloxy)-3'-nitro-[1,1'-biphenyl]-3-carboxylic acid structure

2'-(Benzyloxy)-3'-nitro-[1,1'-biphenyl]-3-carboxylic acid

Eltrombopag Olamine Intermediate

CAS No.
1636137-55-7
M. Formula
C20H15NO5
MW
349.34
Available 3'-Amino-2'-hydroxy-[1,1'-biphenyl]-3-carboxylic Acid structure

3'-Amino-2'-hydroxy-[1,1'-biphenyl]-3-carboxylic Acid

Eltrombopag Olamine Penultimate Intermediate

CAS No.
376592-93-7
M. Formula
C13H11NO3
MW
229.23
Available 3-[5-(1,5-Dioxo-5-(p-fluorophenyl)pentyl]-4(S)-phenyl-2-oxazolidinone structure

3-[5-(1,5-Dioxo-5-(p-fluorophenyl)pentyl]-4(S)-phenyl-2-oxazolidinone

Ezetimibe Intermediate

CAS No.
189028-93-1
M. Formula
C20H18FNO4
MW
355.36
Available Ethyl 2-(3-Cyano-4-isobutoxyphenyl)-4-methylthiazole-5-carboxylate structure

Ethyl 2-(3-Cyano-4-isobutoxyphenyl)-4-methylthiazole-5-carboxylate

Febuxostat Penultimate Intermediate

CAS No.
160844-75-7
M. Formula
C18H20N2O3S
MW
344.43
Available Ethyl 2-(3-Formyl-4-hydroxyphenyl)-4-methylthiazole-5-carboxylate structure

Ethyl 2-(3-Formyl-4-hydroxyphenyl)-4-methylthiazole-5-carboxylate

Febuxostat Intermediate

CAS No.
161798-01-2
M. Formula
C14H13NO4S
MW
291.32
Available 4-(4-Chloro-1-oxobutyl)-α,α-dimethylbenzeneacetic Acid Methyl Ester structure

4-(4-Chloro-1-oxobutyl)-α,α-dimethylbenzeneacetic Acid Methyl Ester

Fexofenadine HCl KSM

CAS No.
154477-54-0
M. Formula
C15H19ClO3
MW
282.76
Available 3-Amino-3-azabicyclo[3,3,0]octane Hydrochloride structure

3-Amino-3-azabicyclo[3,3,0]octane Hydrochloride

Gliclazide KSM

CAS No.
58108-05-7
M. Formula
C7H15ClN2
MW
162.66
Available 4-[(4-Methylpiperazin-1-yl)methyl]benzoic acid dihydrochloride structure

4-[(4-Methylpiperazin-1-yl)methyl]benzoic acid dihydrochloride

Imatinib Mesylate Intermediate

CAS No.
106261-49-8
M. Formula
C13H20Cl2N2O2
MW
307.22
Available N-(5-Amino-2-methylphenyl)-4-(3-pyridyl)-2-pyrimidineamine structure

N-(5-Amino-2-methylphenyl)-4-(3-pyridyl)-2-pyrimidineamine

Imatinib Mesylate Intermediate

CAS No.
152460-10-1
M. Formula
C16H15N5
MW
277.32
Available 3-Bromo-5-(bromoacetyl)salicylamide structure

3-Bromo-5-(bromoacetyl)salicylamide

Labetalol Intermediate

CAS No.
2924103-17-1
M. Formula
C9H7Br2NO3
MW
336.97
Available 5-(2-Bromoacetyl)-2-hydroxybenzamide structure

5-(2-Bromoacetyl)-2-hydroxybenzamide

Labetalol Intermediate

CAS No.
73866-23-6
M. Formula
C9H8BrNO3
MW
258.07
Available 5-(2,2-Dibromoacetyl)-2-hydroxybenzamide structure

5-(2,2-Dibromoacetyl)-2-hydroxybenzamide

Labetalol Intermediate

CAS No.
NA
M. Formula
C9H7Br2NO3
MW
337.0
Available 5-Acetyl salicylamide structure

5-Acetyl salicylamide

Labetalol Intermediate — 5-acetyl salicylamide

CAS No.
40187-51-7
M. Formula
C9H9NO3
MW
179.2
Available 5-Acetyl-3-bromo-2-hydroxybenzamide structure

5-Acetyl-3-bromo-2-hydroxybenzamide

Labetalol Intermediate

CAS No.
NA
M. Formula
C9H8BrNO3
MW
258.07
Available 4-((1H-1,2,4-Triazol-1-yl)methyl)benzonitrile structure

4-((1H-1,2,4-Triazol-1-yl)methyl)benzonitrile

Letrozole Intermediate

CAS No.
112809-25-3
M. Formula
C10H8N4
MW
184.2
Available 4-(4-Cyanobenzyl)-1,2,4-triazole structure

4-(4-Cyanobenzyl)-1,2,4-triazole

Letrozole Impurity

CAS No.
112809-27-5
M. Formula
C10H8N4
MW
184.2
Available 4-[(4-Cyanophenyl)-(1H-1,2,4-triazol-1-yl)methyl]benzamide structure

4-[(4-Cyanophenyl)-(1H-1,2,4-triazol-1-yl)methyl]benzamide

Letrozole MonoAmide Impurity

CAS No.
2500927-47-7
M. Formula
C17H13N5O
MW
303.33
Available 4,4'-((1H-1,2,4-Triazol-1-yl)methylene)dibenzamide structure

4,4'-((1H-1,2,4-Triazol-1-yl)methylene)dibenzamide

Letrozole Diamide Impurity

CAS No.
2170106-13-3
M. Formula
C17H15N5O2
MW
321.34
Available 4,4'-(4H-1,3,4-Triazol-4-ylmethylene)dibenzonitrile structure

4,4'-(4H-1,3,4-Triazol-4-ylmethylene)dibenzonitrile

Letrozole Impurity A

CAS No.
112809-52-6
M. Formula
C17H11N5
MW
285.30
Available 4,4',4''-Methanetriyltribenzonitrile structure

4,4',4''-Methanetriyltribenzonitrile

Letrozole Impurity B

CAS No.
113402-31-6
M. Formula
C22H13N3
MW
319.36
Available N-Acetyl-3,5-diiodotyrosine ethyl ester structure

N-Acetyl-3,5-diiodotyrosine ethyl ester

Levothyroxine Sodium KSM — diiodotyrosine ester

CAS No.
21959-36-4
M. Formula
C13H15I2NO4
MW
503.07
Available (1R)-2-Chloro-1-(2,4-dichlorophenyl)ethan-1-ol structure

(1R)-2-Chloro-1-(2,4-dichlorophenyl)ethan-1-ol

Luliconazole Chiral Intermediate (R-isomer)

CAS No.
114446-57-0
M. Formula
C8H7Cl3O
MW
225.50
Available (1S)-2-Chloro-1-(2,4-dichlorophenyl)ethan-1-ol structure

(1S)-2-Chloro-1-(2,4-dichlorophenyl)ethan-1-ol

Luliconazole Chiral Intermediate (S-isomer)

CAS No.
126534-31-4
M. Formula
C8H7Cl3O
MW
225.50
Available (S)-2-Chloro-1-(2,4-dichlorophenyl)ethyl methanesulfonate structure

(S)-2-Chloro-1-(2,4-dichlorophenyl)ethyl methanesulfonate

Luliconazole Mesylate Intermediate

CAS No.
229334-55-8
M. Formula
C9H9Cl3O3S
MW
303.59
Available 1-(3-Carboxypyrid-2-yl)-2-phenyl-4-methylpiperazine structure

1-(3-Carboxypyrid-2-yl)-2-phenyl-4-methylpiperazine

Mirtazapine Intermediate

CAS No.
61338-13-4
M. Formula
C17H19N3O2
MW
297.36
Available 2-(4-Methyl-2-phenyl-1-piperazinyl)-3-pyridinemethanol structure

2-(4-Methyl-2-phenyl-1-piperazinyl)-3-pyridinemethanol

Mirtazapine Intermediate

CAS No.
61337-89-1
M. Formula
C17H21N3O
MW
283.37
Available (S)-N-(1-Azabicyclo[2.2.2]oct-3-yl)-5,6,7,8-tetrahydro-1-naphthalenecarboxamide structure

(S)-N-(1-Azabicyclo[2.2.2]oct-3-yl)-5,6,7,8-tetrahydro-1-naphthalenecarboxamide

Palonosetron HCl Chiral KSM

CAS No.
135729-78-1
M. Formula
C18H24N2O
MW
284.40
Available Palonosetron-3-ene Hydrochloride structure

Palonosetron-3-ene Hydrochloride

Palonosetron HCl Intermediate

CAS No.
135729-55-4
M. Formula
C19H23ClN2O
MW
330.85
Available 2-((1-Phenoxypropan-2-yl)amino)ethanol structure

2-((1-Phenoxypropan-2-yl)amino)ethanol

Phenoxybenzamine HCl Intermediate

CAS No.
381725-50-4
M. Formula
C11H17NO2
MW
195.26
Available tert-Butyl (3R,5S,E)-7-(2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)-3,5-dihydroxyhept-6-enoate structure

tert-Butyl (3R,5S,E)-7-(2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)-3,5-dihydroxyhept-6-enoate

Pitavastatin Calcium Penultimate Intermediate

CAS No.
586966-54-3
M. Formula
C29H32FNO4
MW
477.57
Available tert-Butyl (3R,5S)-7-[2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl]-3,5-isopropylidenedioxy-6-heptenoate structure

tert-Butyl (3R,5S)-7-[2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl]-3,5-isopropylidenedioxy-6-heptenoate

Pitavastatin Calcium Intermediate

CAS No.
147489-06-3
M. Formula
C32H36FNO4
MW
517.63
Available 6-Methoxy-2-(4-methoxyphenyl)-1-benzothiophene structure

6-Methoxy-2-(4-methoxyphenyl)-1-benzothiophene

Raloxifene HCl KSM — dimethoxybenzothiophene

CAS No.
63675-74-1
M. Formula
C16H14O2S
MW
270.35
Available 2-(2-Aminopropan-2-yl)-N-[(4-fluorophenyl)methyl]-5-hydroxy-1-methyl-6-oxo-1,6-dihydropyrimidine-4-carboxamide structure

2-(2-Aminopropan-2-yl)-N-[(4-fluorophenyl)methyl]-5-hydroxy-1-methyl-6-oxo-1,6-dihydropyrimidine-4-carboxamide

Raltegravir Potassium Intermediate

CAS No.
518048-03-8
M. Formula
C16H19FN4O3
MW
334.35
Available 1-(2-Methoxyphenoxy)-2,3-epoxypropane structure

1-(2-Methoxyphenoxy)-2,3-epoxypropane

Ranolazine KSM — epoxy propane ether

CAS No.
2210-74-4
M. Formula
C10H12O3
MW
180.20
Available N-(2,6-Dimethylphenyl)-2-(piperazin-1-yl)acetamide structure

N-(2,6-Dimethylphenyl)-2-(piperazin-1-yl)acetamide

Ranolazine Intermediate — piperazine acetamide

CAS No.
5294-61-1
M. Formula
C14H21N3O
MW
247.34
Available 1-(2-(Methylamino)ethyl)piperidin-4-yl [1,1'-biphenyl]-2-ylcarbamate structure

1-(2-(Methylamino)ethyl)piperidin-4-yl [1,1'-biphenyl]-2-ylcarbamate

Revefenacin Penultimate Intermediate

CAS No.
743460-48-2
M. Formula
C21H27N3O2
MW
353.47
Available 4-Piperidyl N-(2-biphenyl)carbamate structure

4-Piperidyl N-(2-biphenyl)carbamate

Revefenacin KSM — piperidine biphenyl carbamate

CAS No.
171722-92-2
M. Formula
C18H20N2O2
MW
296.37
Available 4-(3,4-Dichlorophenyl)-3,4-dihydro-1(2H)-naphthalenone (Tetralone) structure

4-(3,4-Dichlorophenyl)-3,4-dihydro-1(2H)-naphthalenone (Tetralone)

Sertraline HCl KSM — Tetralone

CAS No.
79560-19-3
M. Formula
C16H12Cl2O
MW
291.17
Available 4-(3,4-Dichlorophenyl)-N-methyl-3,4-dihydro-2H-naphthalen-1-imine (Schiff-Base) structure

4-(3,4-Dichlorophenyl)-N-methyl-3,4-dihydro-2H-naphthalen-1-imine (Schiff-Base)

Sertraline HCl Schiff-Base Intermediate

CAS No.
79560-20-6
M. Formula
C17H15Cl2N
MW
304.21
Available (R)-3-(7-Cyano-5-(2-((2-(2-(2,2,2-trifluoroethoxy)phenoxy)ethyl)amino)propyl)indolin-1-yl)propyl benzoate oxalate structure

(R)-3-(7-Cyano-5-(2-((2-(2-(2,2,2-trifluoroethoxy)phenoxy)ethyl)amino)propyl)indolin-1-yl)propyl benzoate oxalate

Silodosin Penultimate Intermediate

CAS No.
885340-12-5
M. Formula
C33H36F3N3O7
MW
671.66
Available (R)-(-)-3-Quinuclidinol structure

(R)-(-)-3-Quinuclidinol

Solifenacin Succinate Chiral KSM

CAS No.
25333-42-0
M. Formula
C7H13NO
MW
127.18
Available (S)-1-Phenyl-1,2,3,4-tetrahydroisoquinoline structure

(S)-1-Phenyl-1,2,3,4-tetrahydroisoquinoline

Solifenacin Succinate Chiral Intermediate (S-isomer)

CAS No.
118864-75-8
M. Formula
C15H15N
MW
209.29
Available 1-Phenyl-1,2,3,4-tetrahydroisoquinoline structure

1-Phenyl-1,2,3,4-tetrahydroisoquinoline

Solifenacin Succinate Intermediate (racemic)

CAS No.
22990-19-8
M. Formula
C15H15N
MW
209.29
Available 1,2-Dihydro-1-phenylisoquinoline structure

1,2-Dihydro-1-phenylisoquinoline

Solifenacin Succinate Intermediate

CAS No.
134021-15-1
M. Formula
C15H13N
MW
207.27
Available Ethyl 1-(Ethoxy-2-oxoethyl)piperidine-4-carboxylate structure

Ethyl 1-(Ethoxy-2-oxoethyl)piperidine-4-carboxylate

Solifenacin Succinate Intermediate

CAS No.
1838-39-7
M. Formula
C12H21NO4
MW
243.30
Available Ethyl Isonipecotate structure

Ethyl Isonipecotate

Solifenacin Succinate KSM — ethyl isonipecotate

CAS No.
1126-09-6
M. Formula
C8H15NO2
MW
157.21
Available N-Phenethylbenzamide structure

N-Phenethylbenzamide

Solifenacin Succinate Intermediate

CAS No.
3278-14-6
M. Formula
C15H15NO
MW
225.29
Available 5-Fluorooxindole structure

5-Fluorooxindole

Sunitinib Malate KSM — 5-fluorooxindole

CAS No.
56341-41-4
M. Formula
C8H6FNO
MW
151.14
Available 5-Formyl-2,4-dimethyl-3-pyrrolecarboxylic Acid structure

5-Formyl-2,4-dimethyl-3-pyrrolecarboxylic Acid

Sunitinib Malate KSM

CAS No.
253870-02-9
M. Formula
C8H9NO3
MW
167.16
Available 3,4-Dihydro-2H-pyrrol-5-amine hydrochloride structure

3,4-Dihydro-2H-pyrrol-5-amine hydrochloride

Tipiracil HCl KSM — iminopyrrolidine HCl

CAS No.
7544-75-4
M. Formula
C4H9ClN2
MW
120.58
Available 5-Chloro-6-(chloromethyl)pyrimidine-2,4(1H,3H)-dione structure

5-Chloro-6-(chloromethyl)pyrimidine-2,4(1H,3H)-dione

Tipiracil HCl Intermediate

CAS No.
73742-45-7
M. Formula
C5H4Cl2N2O2
MW
195.00
Available 6-(Chloromethyl)pyrimidine-2,4(1H,3H)-dione structure

6-(Chloromethyl)pyrimidine-2,4(1H,3H)-dione

Tipiracil HCl Intermediate

CAS No.
18592-13-7
M. Formula
C5H5ClN2O2
MW
160.56
Available (1R,4r)-4-(((1r,4R)-4-(aminomethyl)cyclohexanecarboxamido)methyl)cyclohexanecarboxylic acid structure

(1R,4r)-4-(((1r,4R)-4-(aminomethyl)cyclohexanecarboxamido)methyl)cyclohexanecarboxylic acid

Tranexamic acid Impurity-E

CAS No.
82755-59-7
M. Formula
C16H28N2O3
MW
296.41
Available (RS)-4-(Aminomethyl)cyclohex-1-enecarboxylic acid structure

(RS)-4-(Aminomethyl)cyclohex-1-enecarboxylic acid

Tranexamic acid Impurity-C

CAS No.
330838-52-3
M. Formula
C8H13NO2
MW
155.19
Available (trans,trans)-4,4'-(Azanediylbis(methylene))dicyclohexanecarboxylic acid structure

(trans,trans)-4,4'-(Azanediylbis(methylene))dicyclohexanecarboxylic acid

Tranexamic acid Impurity-A

CAS No.
93940-19-3
M. Formula
C16H27NO4
MW
297.39
Available cis-4-(Aminomethyl)cyclohexanecarboxylic acid structure

cis-4-(Aminomethyl)cyclohexanecarboxylic acid

Tranexamic acid Impurity-B

CAS No.
1197-17-7
M. Formula
C8H15NO2
MW
157.21
Available trans-Methyl 4-(aminomethyl)cyclohexanecarboxylate structure

trans-Methyl 4-(aminomethyl)cyclohexanecarboxylate

Tranexamic acid Impurity

CAS No.
50738-63-1
M. Formula
C9H17NO2
MW
171.24
Available (3S,5S,6R)-3-Amino-6-methyl-5-phenyl-1-(2,2,2-trifluoroethyl)piperidin-2-one hydrochloride structure

(3S,5S,6R)-3-Amino-6-methyl-5-phenyl-1-(2,2,2-trifluoroethyl)piperidin-2-one hydrochloride

Ubrogepant Penultimate Intermediate

CAS No.
1375470-88-4
M. Formula
C14H18ClF3N2O
MW
322.75
Available tert-Butyl ((3S,5S,6R)-6-methyl-2-oxo-5-phenyl-1-(2,2,2-trifluoroethyl)piperidin-3-yl)carbamate structure

tert-Butyl ((3S,5S,6R)-6-methyl-2-oxo-5-phenyl-1-(2,2,2-trifluoroethyl)piperidin-3-yl)carbamate

Ubrogepant Intermediate

CAS No.
1456803-35-2
M. Formula
C19H25F3N2O3
MW
386.42
Available (S)-1-(Chloroacetyl)-2-pyrrolidinecarbonitrile structure

(S)-1-(Chloroacetyl)-2-pyrrolidinecarbonitrile

Vildagliptin KSM

CAS No.
207557-35-5
M. Formula
C7H9ClN2O
MW
172.61
Available 3-Aminoadamantan-1-ol structure

3-Aminoadamantan-1-ol

Vildagliptin KSM — adamantanol

CAS No.
702-82-9
M. Formula
C10H17NO
MW
167.25
Available (2R,3S)-rel-3-(6-Chloro-5-fluoropyrimidin-4-yl)-2-(2,4-difluorophenyl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol structure

(2R,3S)-rel-3-(6-Chloro-5-fluoropyrimidin-4-yl)-2-(2,4-difluorophenyl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol

Voriconazole Penultimate Intermediate

CAS No.
137234-75-4
M. Formula
C16H13ClF3N5O
MW
383.76
Available 4-(1-Bromoethyl)-6-chloro-5-fluoropyrimidine structure

4-(1-Bromoethyl)-6-chloro-5-fluoropyrimidine

Voriconazole KSM

CAS No.
188416-28-6
M. Formula
C6H5BrClFN2
MW
239.47

Request a Quote

Need a specific compound not listed here? We can synthesize custom products on request.

Contact Our Team